← Back to Clinical Trials
Recruiting NCT06234384

NCT06234384 Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06234384
Status Recruiting
Phase
Sponsor Foundation for Sarcoidosis Research
Condition Sarcoidosis
Study Type OBSERVATIONAL
Enrollment 6,833 participants
Start Date 2013-07
Primary Completion 2033-06

Trial Parameters

Condition Sarcoidosis
Sponsor Foundation for Sarcoidosis Research
Study Type OBSERVATIONAL
Phase N/A
Enrollment 6,833
Sex ALL
Min Age 7 Years
Max Age N/A
Start Date 2013-07
Completion 2033-06
Interventions
Sarcoidosis diagnosis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of the study is to create a longitudinal record of patient reported outcomes for people living with sarcoidosis that maintains privacy. Patients report on the following: demographics, disease symptoms, diagnostic journey, provider experience, disease treatment, and burden of disease. Patients can also link their Electronic Health Records (EHR). The goal is to create a natural history of sarcoidosis, support research, and better understand the needs of the sarcoidosis community.

Eligibility Criteria

Inclusion Criteria: 1. English speaking 2. Consent 3. Sarcoidosi diagnosis - Exclusion Criteria: NONE

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology